Cargando…
The Discovery of GALM Deficiency (Type IV Galactosemia) and Newborn Screening System for Galactosemia in Japan
The Leloir pathway, which consists of highly conserved enzymes, metabolizes galactose. Deficits in three enzymes in this pathway, namely galactose-1-phosphate uridylyltransferase (GALT), galactokinase (GALK1), and UDP-galactose-4′-epimerase (GALE), are associated with genetic galactosemia. We recent...
Autores principales: | Kikuchi, Atsuo, Wada, Yoichi, Ohura, Toshihiro, Kure, Shigeo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8628924/ https://www.ncbi.nlm.nih.gov/pubmed/34842598 http://dx.doi.org/10.3390/ijns7040068 |
Ejemplares similares
-
Galactosemia: Biochemistry, Molecular Genetics, Newborn Screening, and Treatment
por: Succoio, Mariangela, et al.
Publicado: (2022) -
Screening for galactosemia: is there a place for it?
por: Kotb, Magd A, et al.
Publicado: (2019) -
The Importance of Neonatal Screening for Galactosemia
por: Badiu Tișa, Ioana, et al.
Publicado: (2022) -
Usefulness of serum BUN or BUN/creatinine ratio as markers for citrin deficiency in positive cases of newborn screening
por: Suzuki, Toshihiro, et al.
Publicado: (2021) -
Neonatal Screening: Cost-utility Analysis for Galactosemia
por: HATAM, Nahid, et al.
Publicado: (2017)